Comments
Loading...

Titan Pharma

TTNPNASDAQ
Logo brought to you by Benzinga Data
$3.46
0.195.96%
At close: -
$3.50
0.041.01%
After Hours: Dec 24, 3:57 PM EDT

Titan Pharma (NASDAQ:TTNP) Stock, Analyst Ratings, Price Targets, Forecasts

Quote.Descriptions.analyst-ratings.

Analyst Ratings for Titan Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Titan Pharma (TTNP) stock?

A

The latest price target for Titan Pharma (NASDAQ:TTNP) was reported by Maxim Group on May 26, 2022. The analyst firm set a price target for $0.00 expecting TTNP to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Titan Pharma (TTNP)?

A

The latest analyst rating for Titan Pharma (NASDAQ:TTNP) was provided by Maxim Group, and Titan Pharma downgraded their hold rating.

Q

When was the last upgrade for Titan Pharma (TTNP)?

A

There is no last upgrade for Titan Pharma

Q

When was the last downgrade for Titan Pharma (TTNP)?

A

The last downgrade for Titan Pharmaceuticals Inc happened on May 26, 2022 when Maxim Group changed their price target from N/A to N/A for Titan Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Titan Pharma (TTNP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Titan Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Titan Pharma was filed on May 26, 2022 so you should expect the next rating to be made available sometime around May 26, 2023.

Q

Is the Analyst Rating Titan Pharma (TTNP) correct?

A

While ratings are subjective and will change, the latest Titan Pharma (TTNP) rating was a downgraded with a price target of $0.00 to $0.00. The current price Titan Pharma (TTNP) is trading at is $3.50, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch